메뉴 건너뛰기




Volumn 227, Issue 10, 2012, Pages 3426-3433

Scriptaid effects on breast cancer cell lines

Author keywords

[No Author keywords available]

Indexed keywords

6 (1,3 DIOXO 1H,3H BENZO[DE]ISOQUINOLIN 2 YL) N HYDROXYHEXANAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P21; TAMOXIFEN;

EID: 84862656616     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24043     Document Type: Article
Times cited : (29)

References (36)
  • 1
    • 0022540321 scopus 로고
    • CpG-rich islands and the function of DNA methylation
    • Bird AP. 1986. CpG-rich islands and the function of DNA methylation. Nature 321: 209- 213.
    • (1986) Nature , vol.321 , pp. 209-213
    • Bird, A.P.1
  • 2
    • 15444368857 scopus 로고    scopus 로고
    • Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes
    • Bjornstrom L, Sjoberg M. 2005. Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19: 833- 842.
    • (2005) Mol Endocrinol , vol.19 , pp. 833-842
    • Bjornstrom, L.1    Sjoberg, M.2
  • 3
    • 0141885036 scopus 로고    scopus 로고
    • Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: Synthesis and antiproliferative evaluation
    • Bouchain G, Delorme D. 2003. Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: Synthesis and antiproliferative evaluation. Curr Med Chem 10: 2359- 2372.
    • (2003) Curr Med Chem , vol.10 , pp. 2359-2372
    • Bouchain, G.1    Delorme, D.2
  • 5
    • 84860478434 scopus 로고    scopus 로고
    • Critical choices for modeling breast cancer in transgenic mouse models
    • DOI: 10.1002/jcp.24031.
    • Caligiuri I, Rizzolio F, Boffo S, Giordano A, Toffoli G. 2011. Critical choices for modeling breast cancer in transgenic mouse models. J Cell Physiol DOI: 10.1002/jcp.24031.
    • (2011) J Cell Physiol
    • Caligiuri, I.1    Rizzolio, F.2    Boffo, S.3    Giordano, A.4    Toffoli, G.5
  • 6
    • 32944482243 scopus 로고    scopus 로고
    • Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
    • Cui X, Schiff R, Arpino G, Osborne CK, Lee AV. 2005. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol 23: 7721- 7735.
    • (2005) J Clin Oncol , vol.23 , pp. 7721-7735
    • Cui, X.1    Schiff, R.2    Arpino, G.3    Osborne, C.K.4    Lee, A.V.5
  • 7
    • 0032490874 scopus 로고    scopus 로고
    • Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression
    • Ferguson AT, Lapidus RG, Davidson NE. 1998. Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression. Oncogene 17: 577- 583.
    • (1998) Oncogene , vol.17 , pp. 577-583
    • Ferguson, A.T.1    Lapidus, R.G.2    Davidson, N.E.3
  • 8
    • 82155188552 scopus 로고    scopus 로고
    • The tumor suppressor role of CTCF
    • DOI: 10.1002/jcp.22780.
    • Fiorentino FP, Giordano A. 2012. The tumor suppressor role of CTCF. J Cell Physiol 227: 479- 492. DOI: 10.1002/jcp.22780.
    • (2012) J Cell Physiol , vol.227 , pp. 479-492
    • Fiorentino, F.P.1    Giordano, A.2
  • 9
    • 31444449552 scopus 로고    scopus 로고
    • Epigenetic information and estrogen receptor alpha expression in breast cancer
    • Giacinti L, Claudio PP, Lopez M, Giordano A. 2006. Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 11: 1- 8.
    • (2006) Oncologist , vol.11 , pp. 1-8
    • Giacinti, L.1    Claudio, P.P.2    Lopez, M.3    Giordano, A.4
  • 10
    • 84862637116 scopus 로고    scopus 로고
    • Promise and failure of targeted therapy in breast cancer
    • Giordano A, Tagliabue E, Pupa SM. 2012. Promise and failure of targeted therapy in breast cancer. Front Biosci (Schol Ed) 4: 356- 374.
    • (2012) Front Biosci (Schol Ed) , vol.4 , pp. 356-374
    • Giordano, A.1    Tagliabue, E.2    Pupa, S.M.3
  • 11
    • 0035834786 scopus 로고    scopus 로고
    • Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: Involvement of protein kinase C
    • Han JW, Ahn SH, Kim YK, Bae GU, Yoon JW, Hong S, Lee HY, Lee YW, Lee HW. 2001. Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: Involvement of protein kinase C. J Biol Chem 276: 42084- 42090.
    • (2001) J Biol Chem , vol.276 , pp. 42084-42090
    • Han, J.W.1    Ahn, S.H.2    Kim, Y.K.3    Bae, G.U.4    Yoon, J.W.5    Hong, S.6    Lee, H.Y.7    Lee, Y.W.8    Lee, H.W.9
  • 13
    • 1842422439 scopus 로고    scopus 로고
    • Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer
    • Hanstein B, Djahansouzi S, Dall P, Beckmann MW, Bender HG. 2004. Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer. Eur J Endocrinol 150: 243- 255.
    • (2004) Eur J Endocrinol , vol.150 , pp. 243-255
    • Hanstein, B.1    Djahansouzi, S.2    Dall, P.3    Beckmann, M.W.4    Bender, H.G.5
  • 14
    • 13944274571 scopus 로고    scopus 로고
    • Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding
    • Hu J, Colburn NH. 2005. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Mol Cancer Res 3: 100- 109.
    • (2005) Mol Cancer Res , vol.3 , pp. 100-109
    • Hu, J.1    Colburn, N.H.2
  • 15
    • 0242335773 scopus 로고    scopus 로고
    • Molecular action of the estrogen receptor and hormone dependency in breast cancer
    • Iwase H. 2003. Molecular action of the estrogen receptor and hormone dependency in breast cancer. Breast Cancer 10: 89- 96.
    • (2003) Breast Cancer , vol.10 , pp. 89-96
    • Iwase, H.1
  • 17
    • 0142122363 scopus 로고    scopus 로고
    • Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha
    • Kawai H, Li H, Avraham S, Jiang S, Avraham HK. 2003. Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int J Cancer 107: 353- 358.
    • (2003) Int J Cancer , vol.107 , pp. 353-358
    • Kawai, H.1    Li, H.2    Avraham, S.3    Jiang, S.4    Avraham, H.K.5
  • 18
    • 0242330341 scopus 로고    scopus 로고
    • A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine
    • Keen JC, Yan L, Mack KM, Pettit C, Smith D, Sharma D, Davidson NE. 2003. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine. Breast Cancer Res Treat 81: 177- 186.
    • (2003) Breast Cancer Res Treat , vol.81 , pp. 177-186
    • Keen, J.C.1    Yan, L.2    Mack, K.M.3    Pettit, C.4    Smith, D.5    Sharma, D.6    Davidson, N.E.7
  • 20
    • 0031597992 scopus 로고    scopus 로고
    • The loss of estrogen and progesterone receptor gene expression in human breast cancer
    • Lapidus RG, Nass SJ, Davidson NE. 1998b. The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol Neoplasia 3: 85- 94.
    • (1998) J Mammary Gland Biol Neoplasia , vol.3 , pp. 85-94
    • Lapidus, R.G.1    Nass, S.J.2    Davidson, N.E.3
  • 21
    • 85077951985 scopus 로고    scopus 로고
    • The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
    • Marks PA. 2004. The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA). Cell Cycle 3: 534- 535.
    • (2004) Cell Cycle , vol.3 , pp. 534-535
    • Marks, P.A.1
  • 22
    • 2942724589 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: Development as cancer therapy
    • discussion 281-288.
    • Marks PA, Richon VM, Kelly WK, Chiao JH, Miller T. 2004. Histone deacetylase inhibitors: Development as cancer therapy. Novartis Found Symp 259: 269- 281; discussion 281-288.
    • (2004) Novartis Found Symp , vol.259 , pp. 269-281
    • Marks, P.A.1    Richon, V.M.2    Kelly, W.K.3    Chiao, J.H.4    Miller, T.5
  • 23
    • 0037204724 scopus 로고    scopus 로고
    • Connections and regulation of the human estrogen receptor
    • McDonnell DP, Norris JD. 2002. Connections and regulation of the human estrogen receptor. Science 296: 1642- 1644.
    • (2002) Science , vol.296 , pp. 1642-1644
    • McDonnell, D.P.1    Norris, J.D.2
  • 24
    • 0037462733 scopus 로고    scopus 로고
    • Proximal events in signaling by plasma membrane estrogen receptors
    • Razandi M, Pedram A, Park ST, Levin ER. 2003. Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278: 2701- 2712.
    • (2003) J Biol Chem , vol.278 , pp. 2701-2712
    • Razandi, M.1    Pedram, A.2    Park, S.T.3    Levin, E.R.4
  • 25
    • 0038079767 scopus 로고    scopus 로고
    • The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1
    • Rosato RR, Almenara JA, Grant S. 2003. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. Cancer Res 63: 3637- 3645.
    • (2003) Cancer Res , vol.63 , pp. 3637-3645
    • Rosato, R.R.1    Almenara, J.A.2    Grant, S.3
  • 26
    • 0033520944 scopus 로고    scopus 로고
    • Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects
    • Sambucetti LC, Fischer DD, Zabludoff S, Kwon PO, Chamberlin H, Trogani N, Xu H, Cohen D. 1999. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem 274: 34940- 34947.
    • (1999) J Biol Chem , vol.274 , pp. 34940-34947
    • Sambucetti, L.C.1    Fischer, D.D.2    Zabludoff, S.3    Kwon, P.O.4    Chamberlin, H.5    Trogani, N.6    Xu, H.7    Cohen, D.8
  • 27
    • 25844509783 scopus 로고    scopus 로고
    • Steroid hormone receptor signaling in tumorigenesis
    • Singh RR, Kumar R. 2005. Steroid hormone receptor signaling in tumorigenesis. J Cell Biochem 96: 490- 505.
    • (2005) J Cell Biochem , vol.96 , pp. 490-505
    • Singh, R.R.1    Kumar, R.2
  • 28
    • 0034124166 scopus 로고    scopus 로고
    • A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library
    • Su GH, Sohn TA, Ryu B, Kern SE. 2000. A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. Cancer Res 60: 3137- 3142.
    • (2000) Cancer Res , vol.60 , pp. 3137-3142
    • Su, G.H.1    Sohn, T.A.2    Ryu, B.3    Kern, S.E.4
  • 29
    • 33644863529 scopus 로고    scopus 로고
    • A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells
    • Takai N, Ueda T, Nishida M, Nasu K, Narahara H. 2006. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells. Int J Mol Med 17: 323- 329.
    • (2006) Int J Mol Med , vol.17 , pp. 323-329
    • Takai, N.1    Ueda, T.2    Nishida, M.3    Nasu, K.4    Narahara, H.5
  • 30
    • 0036176617 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors in cancer treatment
    • Vigushin DM, Coombes RC. 2002. Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs 13: 1- 13.
    • (2002) Anticancer Drugs , vol.13 , pp. 1-13
    • Vigushin, D.M.1    Coombes, R.C.2
  • 32
    • 0027295315 scopus 로고
    • Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma
    • Weigel RJ, deConinck EC. 1993. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res 53: 3472- 3474.
    • (1993) Cancer Res , vol.53 , pp. 3472-3474
    • Weigel, R.J.1    deConinck, E.C.2
  • 33
    • 1542787625 scopus 로고    scopus 로고
    • Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines
    • Yan L, Nass SJ, Smith D, Nelson WG, Herman JG, Davidson NE. 2003. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines. Cancer Biol Ther 2: 552- 556.
    • (2003) Cancer Biol Ther , vol.2 , pp. 552-556
    • Yan, L.1    Nass, S.J.2    Smith, D.3    Nelson, W.G.4    Herman, J.G.5    Davidson, N.E.6
  • 35
    • 0035477320 scopus 로고    scopus 로고
    • Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells
    • Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE. 2001. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res 61: 7025- 7029.
    • (2001) Cancer Res , vol.61 , pp. 7025-7029
    • Yang, X.1    Phillips, D.L.2    Ferguson, A.T.3    Nelson, W.G.4    Herman, J.G.5    Davidson, N.E.6
  • 36
    • 0034522739 scopus 로고    scopus 로고
    • Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: Methylation of the gene and alteration of trans-acting factors
    • Yoshida T, Eguchi H, Nakachi K, Tanimoto K, Higashi Y, Suemasu K, Iino Y, Morishita Y, Hayashi S. 2000. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: Methylation of the gene and alteration of trans-acting factors. Carcinogenesis 21: 2193- 2201.
    • (2000) Carcinogenesis , vol.21 , pp. 2193-2201
    • Yoshida, T.1    Eguchi, H.2    Nakachi, K.3    Tanimoto, K.4    Higashi, Y.5    Suemasu, K.6    Iino, Y.7    Morishita, Y.8    Hayashi, S.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.